Healthcare provider profile · identity verified

Scott W Burk, MD

Internal Medicine · ALVA, OK · NPI 1538271465

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	403	96
Atorvastatin Calcium	Atorvastatin Calcium	387	96
Omeprazole	Omeprazole	255	62
Gabapentin	Gabapentin	246	57
Losartan Potassium	Losartan Potassium	231	55
Metformin Hcl	Metformin Hcl	219	49
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	202	33
Lisinopril	Lisinopril	202	55
Metoprolol Succinate	Metoprolol Succinate	200	51
Pantoprazole Sodium	Pantoprazole Sodium	189	46
Amlodipine Besylate	Amlodipine Besylate	188	47
Eliquis	Apixaban	173	23
Furosemide	Furosemide	158	39
Tramadol Hcl	Tramadol Hcl	157	34
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	148	34
Rosuvastatin Calcium	Rosuvastatin Calcium	146	42
Montelukast Sodium	Montelukast Sodium	142	48
Tamsulosin Hcl	Tamsulosin Hcl	139	35
Meloxicam	Meloxicam	130	37
Potassium Chloride	Potassium Chloride	129	36
Escitalopram Oxalate	Escitalopram Oxalate	118	23
Hydrochlorothiazide	Hydrochlorothiazide	113	30
Simvastatin	Simvastatin	112	31
Celecoxib	Celecoxib	105	22
Allopurinol	Allopurinol	104	23
Ezetimibe	Ezetimibe	101	18
Alprazolam	Alprazolam	100	15
Jardiance	Empagliflozin	91	15
Lorazepam	Lorazepam	91	19
Clopidogrel	Clopidogrel Bisulfate	88	27
Duloxetine Hcl	Duloxetine Hcl	86	16
Atenolol	Atenolol	85	19
Carvedilol	Carvedilol	81	23
Terazosin Hcl	Terazosin Hcl	80	18
Albuterol Sulfate Hfa	Albuterol Sulfate	78	22
Pravastatin Sodium	Pravastatin Sodium	77	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	76	17
Ozempic	Semaglutide	76	12
Zolpidem Tartrate	Zolpidem Tartrate	75	12
Metoprolol Tartrate	Metoprolol Tartrate	73	19
Pregabalin	Pregabalin	73	12
Buspirone Hcl	Buspirone Hcl	71	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	70	19
Doxazosin Mesylate	Doxazosin Mesylate	67	18
Glimepiride	Glimepiride	67	17
Januvia	Sitagliptin Phosphate	66	suppressed
Finasteride	Finasteride	61	12
Glipizide	Glipizide	60	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	58	suppressed
Trazodone Hcl	Trazodone Hcl	51	14
Famotidine	Famotidine	50	14
Estradiol	Estradiol	49	14
Glipizide Er	Glipizide	48	13
Felodipine Er	Felodipine	46	suppressed
Paroxetine Hcl	Paroxetine Hcl	46	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	46	26
Azithromycin	Azithromycin	45	41
Ropinirole Hcl	Ropinirole Hcl	43	11
Synthroid	Levothyroxine Sodium	43	suppressed
Donepezil Hcl	Donepezil Hcl	42	13
Citalopram Hbr	Citalopram Hydrobromide	41	suppressed
Clonidine Hcl	Clonidine Hcl	41	suppressed
Myrbetriq	Mirabegron	41	suppressed
Prednisone	Prednisone	41	33
Oxycodone Hcl	Oxycodone Hcl	40	suppressed
Fluticasone Propionate	Fluticasone Propionate	39	15
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Amiodarone Hcl	Amiodarone Hcl	37	suppressed
Warfarin Sodium	Warfarin Sodium	37	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	36	suppressed
Lovastatin	Lovastatin	35	suppressed
Sertraline Hcl	Sertraline Hcl	35	suppressed
Temazepam	Temazepam	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Spironolactone	Spironolactone	34	12
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	21
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	11
Ondansetron Odt	Ondansetron	33	12
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Raloxifene Hcl	Raloxifene Hcl	32	suppressed
Ibandronate Sodium	Ibandronate Sodium	31	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Farxiga	Dapagliflozin Propanediol	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	20
Sucralfate	Sucralfate	29	suppressed
Aripiprazole	Aripiprazole	28	suppressed
Diazepam	Diazepam	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Brilinta	Ticagrelor	25	suppressed
Bumetanide	Bumetanide	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	14
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Metformin Hcl Er	Metformin Hcl	24	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Torsemide	Torsemide	22	suppressed
Guanfacine Hcl	Guanfacine Hcl	21	suppressed
Levofloxacin	Levofloxacin	21	17
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Belsomra	Suvorexant	20	suppressed
Clonazepam	Clonazepam	20	suppressed
Naproxen	Naproxen	20	suppressed
Cholestyramine	Cholestyramine (With Sugar)	19	suppressed
Methimazole	Methimazole	19	suppressed
Nystatin	Nystatin	19	suppressed
Fluconazole	Fluconazole	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Primidone	Primidone	18	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Modafinil	Modafinil	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Azathioprine	Azathioprine	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Np Thyroid	Thyroid,pork	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error